Lv4
540 积分 2025-07-15 加入
An in situ engineered chimeric IL-2 receptor potentiates the tumoricidal activity of proinflammatory CAR macrophages in renal cell carcinoma
23天前
已完结
Capturing intrinsic protein dynamics for explaining beneficial substitutions from protein engineering campaigns
24天前
已完结
Chimeric antigen receptor therapies: Development, design, and implementation
24天前
已完结
Iterative recombinase technologies for efficient and precise genome engineering across kilobase to megabase scales
24天前
已完结
Engineering TCR-controlled fuzzy logic into CAR T cells enhances therapeutic specificity
24天前
已完结
Advancing protein evolution with inverse folding models integrating structural and evolutionary constraints
1个月前
已完结
Therapeutic mRNA vaccine applications in oncology
1个月前
已完结
Effective design of therapeutic nanovaccines based on tumor neoantigens
1个月前
已完结
皖公网安备34019202002308
